These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 37866808)
21. Valproic Acid Promotes Human Glioma U87 Cells Apoptosis and Inhibits Glycogen Synthase Kinase-3β Through ERK/Akt Signaling. Zhang C; Liu S; Yuan X; Hu Z; Li H; Wu M; Yuan J; Zhao Z; Su J; Wang X; Liao Y; Liu Q Cell Physiol Biochem; 2016; 39(6):2173-2185. PubMed ID: 27802437 [TBL] [Abstract][Full Text] [Related]
22. The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling. Zhou XL; Guo X; Song YP; Zhu CY; Zou W Acta Pharmacol Sin; 2018 Mar; 39(3):459-471. PubMed ID: 29188802 [TBL] [Abstract][Full Text] [Related]
23. Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB2 receptor agonists: identifying novel GPR55 inhibitors. Anavi-Goffer S; Irving AJ; Ross RA J Basic Clin Physiol Pharmacol; 2016 May; 27(3):303-10. PubMed ID: 27089417 [TBL] [Abstract][Full Text] [Related]
24. A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells. Ford LA; Roelofs AJ; Anavi-Goffer S; Mowat L; Simpson DG; Irving AJ; Rogers MJ; Rajnicek AM; Ross RA Br J Pharmacol; 2010 Jun; 160(3):762-71. PubMed ID: 20590578 [TBL] [Abstract][Full Text] [Related]
25. Abnormal spatiotemporal expression pattern of progranulin and neurodevelopment impairment in VPA-induced ASD rat model. Lan J; Hu Y; Wang X; Zheng W; Liao A; Wang S; Li Y; Wang Y; Yang F; Chen D Neuropharmacology; 2021 Sep; 196():108689. PubMed ID: 34175324 [TBL] [Abstract][Full Text] [Related]
26. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells. Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382 [TBL] [Abstract][Full Text] [Related]
27. Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells. Obara Y; Ueno S; Yanagihata Y; Nakahata N PLoS One; 2011; 6(8):e24284. PubMed ID: 21904624 [TBL] [Abstract][Full Text] [Related]
28. Regulation of valproic acid induced EMT by AKT/GSK3β/β-catenin signaling pathway in triple negative breast cancer. Ozman Z; Ozbek Iptec B; Sahin E; Guney Eskiler G; Deveci Ozkan A; Kaleli S Mol Biol Rep; 2021 Feb; 48(2):1335-1343. PubMed ID: 33515347 [TBL] [Abstract][Full Text] [Related]
29. O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice. Kang S; Lee AY; Park SY; Liu KH; Im DS Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803038 [TBL] [Abstract][Full Text] [Related]
30. Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells. Harada K; Kitaguchi T; Kamiya T; Aung KH; Nakamura K; Ohta K; Tsuboi T J Biol Chem; 2017 Jun; 292(26):10855-10864. PubMed ID: 28533434 [TBL] [Abstract][Full Text] [Related]
31. 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55. Oka S; Toshida T; Maruyama K; Nakajima K; Yamashita A; Sugiura T J Biochem; 2009 Jan; 145(1):13-20. PubMed ID: 18845565 [TBL] [Abstract][Full Text] [Related]
32. Progranulin improves neural development via the PI3K/Akt/GSK-3β pathway in the cerebellum of a VPA-induced rat model of ASD. Wang L; Chen J; Hu Y; Liao A; Zheng W; Wang X; Lan J; Shen J; Wang S; Yang F; Wang Y; Li Y; Chen D Transl Psychiatry; 2022 Mar; 12(1):114. PubMed ID: 35318322 [TBL] [Abstract][Full Text] [Related]
33. The L-α-Lysophosphatidylinositol/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis. Fondevila MF; Fernandez U; Gonzalez-Rellan MJ; Da Silva Lima N; Buque X; Gonzalez-Rodriguez A; Alonso C; Iruarrizaga-Lejarreta M; Delgado TC; Varela-Rey M; Senra A; Garcia-Outeiral V; Novoa E; Iglesias C; Porteiro B; Beiroa D; Folgueira C; Tojo M; Torres JL; Hernández-Cosido L; Blanco Ó; Arab JP; Barrera F; Guallar D; Fidalgo M; López M; Dieguez C; Marcos M; Martinez-Chantar ML; Arrese M; Garcia-Monzon C; Mato JM; Aspichueta P; Nogueiras R Hepatology; 2021 Feb; 73(2):606-624. PubMed ID: 32329085 [TBL] [Abstract][Full Text] [Related]
34. What is the natural ligand of GPR55? Okuno T; Yokomizo T J Biochem; 2011 May; 149(5):495-7. PubMed ID: 21324983 [TBL] [Abstract][Full Text] [Related]
35. A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity. Hurst K; Badgley C; Ellsworth T; Bell S; Friend L; Prince B; Welch J; Cowan Z; Williamson R; Lyon C; Anderson B; Poole B; Christensen M; McNeil M; Call J; Edwards JG Hippocampus; 2017 Sep; 27(9):985-998. PubMed ID: 28653801 [TBL] [Abstract][Full Text] [Related]
36. All-trans-retinoid acid induces the differentiation of P19 cells into neurons involved in the PI3K/Akt/GSK3β signaling pathway. Fu F; Li LS; Li R; Deng Q; Yu QX; Yang X; Pan M; Han J; Zhen L; Zhang LN; Lei TY; Li DZ; Liao C J Cell Biochem; 2020 Nov; 121(11):4386-4396. PubMed ID: 31961017 [TBL] [Abstract][Full Text] [Related]
37. Qiliqiangxin Attenuates Oxidative Stress-Induced Mitochondrion-Dependent Apoptosis in Cardiomyocytes via PI3K/AKT/GSK3β Signaling Pathway. Zhao Q; Li H; Chang L; Wei C; Yin Y; Bei H; Wang Z; Liang J; Wu Y Biol Pharm Bull; 2019 Aug; 42(8):1310-1321. PubMed ID: 31142701 [TBL] [Abstract][Full Text] [Related]
38. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity? Nevalainen T; Irving AJ Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712 [TBL] [Abstract][Full Text] [Related]
39. [Electroacupuncture regulates glucose metabolism disorder through PI3K/Akt/GSK3β signaling pathway in rats with depression]. Lu YJ; Shao C; Zhang S; Shi W; Li L; Zhao JJ Zhen Ci Yan Jiu; 2023 Mar; 48(3):247-52. PubMed ID: 36951076 [TBL] [Abstract][Full Text] [Related]
40. G protein-coupled estrogen receptor (GPER) selective agonist G1 attenuates the neurobehavioral, molecular and biochemical alterations induced in a valproic acid rat model of autism. Hameed RA; Ahmed EK; Mahmoud AA; Atef AA Life Sci; 2023 Sep; 328():121860. PubMed ID: 37331505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]